These results suggest that, serum selenium, zinc, and copper levels may be important in evaluation of bladder cancer.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Serum levels of selenium, zinc and copper were measured in 51 patients with bladder cancer (15 patients in Grade I, 7 9 patients in Grade II and 17 patients in Grade III) and 22 healthy controls.
📊
Key Findings & Data:Decreased serum levels of selenium was found in cancer patients in Grade III while zinc levels decreased in Grade II and III when compared with control group.
💡
Conclusion & Impact:These results suggest that, serum selenium, zinc, and copper levels may be important in evaluation of bladder cancer.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Serum levels of selenium, zinc and copper were measured in 51 patients with bladder cancer (15 patients in Grade I, 7 9 patients in Grade II and 17 patients in Grade III) and 22 healthy controls. Decreased serum levels of selenium was found in cancer patients in Grade III while zinc levels decreased in Grade II and III when compared with control group. Serum copper levels were found statistically higher in patients in every stages when compared to control group. These results suggest that, serum selenium, zinc, and copper levels may be important in evaluation of bladder cancer.
🔖
Cite This Article
SUNGUROĞLU, K., PEKER, A. F., KILINÇ, C. (2022). Blood selenium, zinc and copper levels in patients with bladder cancer. Journal of Ankara Medical School, Cilt: 21 - Sayı: 1, 1–3. https://ajindex.com/articles/560070